Although Braun et al. did not divide sarcoidosis patients by subsequent prognosis, our results suggest that patients with low % CD4+ T-cell proliferation may improve, while patients with high % CD4+ T-cell proliferation may remain unchanged or worsen. The gene discussed is CD4; the disease is sarcoidosis.